Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 145
Halcion: An Independent Assessment of Safety and Efficacy Data D Acronyms ANOVA analysis of variance CDER Center for Drug Evaluation and Research (FDA) CNS central nervous system CPMP Committee on Proprietary Medicinal Products (European Union) CSM Committee on the Safety of Medicines (United Kingdom) EEG electroencephalogram EMIC Evaluation of Medications for Insomnia in Canada FDA U.S. Food and Drug Administration IOM Institute of Medicine ISS Integrated Summary of Safety MCA Medicines Control Agency (United Kingdom) MHPG methoxyhydroxyphenylglycol NDA New Drug Application NDTI National Disease and Therapeutic Index NPA National Prescription Audit PAAC Psychopharmacologic Agents Advisory Committee PDAC Psychopharmacologic Drugs Advisory Committee PLMS periodic limb movements of sleep REM rapid eye movement SPECT single photon emission computerized tomography SRS Spontaneous Reporting System VAMP Value Added Medicinal Products Research
Representative terms from entire chapter: